Dyspepsia in Early Pregnancy as a Result of Hormonal and Functional Changes: A Case Report
DOI:
https://doi.org/10.51601/ijhp.v6i1.541Abstract
Introduction: Dyspepsia is a common gastrointestinal complaint in early pregnancy, generally associated with hormonal and functional changes. This condition may reduce quality of life, affect maternal nutritional status, and present a diagnostic challenge in differentiating it from other conditions such as hyperemesis gravidarum or gastrointestinal infection. Case Report: A 27-year-old woman, G1P0A0, at 10 weeks of gestation, presented with nausea and vomiting more than two times per day, accompanied by epigastric discomfort and bloating after meals. Physical examination revealed epigastric tenderness without signs of severe dehydration. Laboratory tests showed normal hemoglobin, mildly elevated leukocytes, slightly decreased potassium, and the presence of bacteria and leukocytes in urine. Result: A working diagnosis of dyspepsia in early pregnancy was established after ruling out hyperemesis gravidarum and gastroenteritis. The patient was treated with Ringer’s lactate infusion, intravenous ondansetron, antacids, and vitamin B complex supplementation, which led to improvement of symptoms. Conclusion: Dyspepsia during pregnancy is a common complaint with both hormonal and functional etiologies. Diagnosis requires thorough history-taking and exclusion of important differential diagnoses. Management should prioritize lifestyle modification and supportive therapy, with safe pharmacotherapy during pregnancy when necessary
Downloads
References
[1] F. G. Cunningham et al., Williams obstetrics, vol. 7. McGraw-Hill Medical New York, 2014. [Online]. Available: http://studiofantino.it/userfiles/files/xanepegovizagewuwoko.pdf
[2] A. C. Ford, S. Mahadeva, M. F. Carbone, B. E. Lacy, and N. J. Talley, “Functional dyspepsia,” Lancet, vol. 396, no. 10263, pp. 1689–1702, Apr. 2020.
[3] A. E. Bharucha, S. D. Dorn, A. Lembo, and A. Pressman, “American Gastroenterological Association medical position statement on constipation,” Gastroenterology, vol. 144, no. 1, pp. 211–217, May 2013, [Online]. Available: https://www.gastrojournal.org/article/S0016-5085(12)01545-4/abstract
[4] A. M. Caballero-Mateos et al., “Risk factors for functional dyspepsia, erosive and non-erosive gastroesophageal reflux disease: A cross-sectional study,” Gastroenterol. Hepatol., vol. 46, no. 7, pp. 542–552, Apr. 2023.
[5] T. M. Aries and I. Rey, “The Relationship Between Stress and Anxiety with the Occurrence of Functional Dyspepsia among Medical Students of Sumatera Utara University,” Indones. J. Gastroenterol. Hepatol. Dig. Endosc., vol. 25, no. 3, pp. 233–238, Apr. 2024.
[6] K. R. Duncanson, N. J. Talley, M. M. Walker, and T. L. Burrows, “Food and functional dyspepsia: a systematic review,” J. Hum. Nutr. Diet., vol. 31, no. 3, pp. 390–407, Apr. 2018, doi: 10.1111/jhn.12506.
[7] S. Rahayu and W. E. Pertiwi, “Factors Related to the Incident of Dyspepsia Syndrome,” KnE Soc. Sci., pp. 290–299, Apr. 2023, [Online]. Available: https://knepublishing.com/index.php/KnE-Social/article/view/13838
[8] S. Byonanuwe et al., “Predictors of Premature Rupture of Membranes among Pregnant Women in Rural Uganda: A Cross-Sectional Study at a Tertiary Teaching Hospital,” Int. J. Reprod. Med., vol. 2020, pp. 1–6, Apr. 2020, doi: 10.1155/2020/1862786.
[9] F. N. Akbar, A. A. Ahmadi, and H. Hendarto, “Association between Eating Habits and Types of Food Intake with Functional Dyspepsia Among First-Year Clinical and First-Year Pre-Clinical Students in the Faculty of Medicine State Islamic University Jakarta,” Apr. 2023.
[10] A. N. Pilichiewicz, M. Horowitz, G. J. Holtmann, N. J. Talley, and C. Feinle–Bisset, “Relationship between symptoms and dietary patterns in patients with functional dyspepsia,” Clin. Gastroenterol. Hepatol., vol. 7, no. 3, pp. 317–322, Apr. 2009.
[11] Y.-P. Wang, C. C. Herndon, and C.-L. Lu, “Non-pharmacological approach in the management of functional dyspepsia,” J. Neurogastroenterol. Motil., vol. 26, no. 1, p. 6, Apr. 2020.
[12] D. S, D. A. Novri, Y. Hamidy, and M. Savira, “Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.,” F1000research, vol. 11, pp. 1287–1287, Jan. 2022, doi: 10.12688/F1000RESEARCH.125944.2.
[13] S. Rana, E. Lemoine, J. P. Granger, and S. A. Karumanchi, “Preeclampsia: Pathophysiology, Challenges, and Perspectives,” Circ. Res., vol. 124, no. 7, pp. 1094–1112, May 2019, doi: 10.1161/CIRCRESAHA.118.313276.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Abitmer Gultom
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
